Toboroz
A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07915791· 2. fázis· GlaxoSmithKline· Forrás
Contact: Andrew Pastewski (principal investigator)
Toboroz
A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age
NCT07851246· 3. fázis· GlaxoSmithKline· Forrás
Contact: Rafael Ubeda (principal investigator)
Toboroz
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
NCT07780656· 3. fázis· GlaxoSmithKline· Forrás
Contact: David Romero-Fischmann (principal investigator)
Toboroz
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
NCT07805707· 3. fázis· GlaxoSmithKline· Forrás
Contact: Pedro San Martin Parra (principal investigator)
Toboroz
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
NCT07645248· 3. fázis· GlaxoSmithKline· Forrás
Contact: Eduardo Martinez (principal investigator)
Toboroz
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
NCT07782996· 3. fázis· GlaxoSmithKline· Forrás
Contact: Omar Benitez (principal investigator)
Toboroz
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
NCT07701993· 3. fázis· GlaxoSmithKline· Forrás
Contact: Yaneicy Gonzalez Rojas (principal investigator)
Toboroz
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
NCT07704892· 3. fázis· GlaxoSmithKline· Forrás
Contact: Yaneicy Gonzalez Rojas (principal investigator)
Toboroz
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
NCT07650916· 3. fázis· ViiV Healthcare· Forrás
Contact: Charles Mitchell (principal investigator)
Toboroz
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
NCT07519395· 2. fázis· GlaxoSmithKline· Forrás
Contact: Onix Garib Alpizar (principal investigator)
Toboroz
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
NCT07456033· 3. fázis· GlaxoSmithKline· Forrás
Contact: Mark Kutner (principal investigator)
Toboroz
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
NCT07464314· 1. fázis· GlaxoSmithKline· Forrás
Contact: Rafael Ubeda (principal investigator)
Toboroz
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
NCT07202546· 2. fázis· ViiV Healthcare· Forrás
Contact: Dushyantha Jayaweera (principal investigator)
Toboroz
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
NCT07221188· 3. fázis· GlaxoSmithKline· Forrás
Contact: Yaneicy Gonzalez Rojas (principal investigator)
Toboroz
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
NCT07201051· 2. fázis· GlaxoSmithKline· Forrás
Contact: Maria Campos-Yatzkan (principal investigator)
Toboroz
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
NCT07221227· 3. fázis· GlaxoSmithKline· Forrás
Contact: Yaneicy Gonzalez Rojas (principal investigator)
Toboroz
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
NCT07177339· 3. fázis· GlaxoSmithKline· Forrás
Contact: Ibrahim Menendez-Perez (principal investigator)
Toboroz
Open-label Extension Study in Participants With Early Alzheimer's Disease
NCT07105709· 2. fázis· GlaxoSmithKline· Forrás
Contact: Ramon Leon (principal investigator)
Toboroz
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
NCT07099898· 3. fázis· GlaxoSmithKline· Forrás
Contact: Francisco Belette (principal investigator)
Toboroz
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214· 3. fázis· GlaxoSmithKline· Forrás
Contact: Armando Ropero Cartier (principal investigator)
Toboroz
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
NCT06959095· 3. fázis· GlaxoSmithKline· Forrás
Contact: Anish Dhadwal (principal investigator)
Toboroz
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
NCT06920043· 2. fázis· GlaxoSmithKline· Forrás
Contact: Lazaro M Garcia (principal investigator)
Fut, nem toboroz
A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma
NCT06748053· 2. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
NCT06694805· 3. fázis· ViiV Healthcare· Forrás
Toboroz
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT06613698· 2. fázis· GlaxoSmithKline· Forrás
Contact: Barbara Moscoso (principal investigator)
Fut, nem toboroz
Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma
NCT06372496· 4. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
NCT06041386· 4. fázis· GlaxoSmithKline· Forrás
Toboroz
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717· 2/3. fázis· GlaxoSmithKline· Forrás
Contact: Luis Ramos Gonez (principal investigator)
Fut, nem toboroz
A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
NCT05996471· 2. fázis· ViiV Healthcare· Forrás
Toboroz
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
NCT05674656· 1/2. fázis· ViiV Healthcare· Forrás
Contact: Charles Mitchell (principal investigator)
Fut, nem toboroz
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
NCT05757102· 3. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents
NCT05087056· 2. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
Linerixibat Long-term Safety, and Tolerability Study
NCT04167358· 3. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
NCT03981796· 3. fázis· Tesaro, Inc.· Forrás
Fut, nem toboroz
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
NCT02655016· 3. fázis· Tesaro, Inc.· Forrás
Fut, nem toboroz
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
NCT02817633· 1. fázis· Tesaro, Inc.· Forrás
Fut, nem toboroz
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors
NCT02715284· 1. fázis· Tesaro, Inc.· Forrás